adapalene has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Ding, J; Feng, Z; Huang, K; Li, X; Liu, M; Ma, J; Wang, Y; Yin, S; Zhang, H; Zhang, M; Zhang, R | 1 |
| Alblowi, J; Coimbra, LS; Einhorn, TA; Gerstenfeld, LC; Graves, DT; Kayal, RA; Ko, KI; Pignolo, RJ; Tian, C | 1 |
2 other study(ies) available for adapalene and Alloxan Diabetes
| Article | Year |
|---|---|
CD271 promotes STZ-induced diabetic wound healing and regulates epidermal stem cell survival in the presence of the pTrkA receptor.
Topics: Adapalene; Animals; Carbazoles; Cell Movement; Cell Proliferation; Cell Survival; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epidermal Cells; Indole Alkaloids; Male; Mice; Mice, Inbred C57BL; Receptor, trkA; Stem Cell Transplantation; Stem Cells; Wound Healing | 2020 |
Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism.
Topics: Adapalene; Animals; Antigens, Ly; Apoptosis; Cell Line; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fracture Healing; Humans; Membrane Proteins; Mesenchymal Stem Cells; Mice; Osteogenesis; Tumor Necrosis Factor-alpha | 2015 |